Kurt Boman

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis

Anne B. Rossebø, Terje R. Pedersen, Kurt Boman et al. · New England Journal of Medicine · 2008 · 1.6K citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

High Plasminogen Activator Inhibitor and Tissue Plasminogen Activator Levels in Plasma Precede a First Acute Myocardial Infarction in Both Men and Women

Anna Margrethe Thøgersen, Jan‐Håkan Jansson, Kurt Boman et al. · Circulation · 1998 · 602 citations · Full text

Medicine, Cardiology, Clinical Cardiology +13

Regression of Hypertensive Left Ventricular Hypertrophy by Losartan Compared With Atenolol

Richard B. Devereux, Björn Dahlöf, Eva Gerdts et al. · Circulation · 2004 · 472 citations

Medicine, Cardiology, Pharmacotherapy +17